Status:
UNKNOWN
Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
Lead Sponsor:
Hôpital Cochin
Conditions:
Arthritis, Rheumatoid
Spondyloarthritis
Eligibility:
All Genders
18+ years
Brief Summary
There is a lack of knowledge among patients concerning their treatment with bDMARDs. To increase knowledge and safety skills, patient education is essential. The aim of this study is to assess the im...
Detailed Description
This is an observational, controlled, open-label and monocentric study. 60 patients are planned to be included. Knowledge are assessed three time by self-administered questionnaire: at baseline befo...
Eligibility Criteria
Inclusion
- Patients must be able to understand and communicate in French and comply with the requirements of the study and must give his agreement (non-opposition) before any study assessment is performed.
- Patient at least 18 years of age
- Patient with inflammatory arthritis (rheumatoid arthritis or ankylosing spondylitis or other)
- Admission in medical consultation in the rheumatology department
- Patient treated with subcutaneous biologic DMARDs (Tocilizumab, Adalimumab, Etanercept, Golimumab, Certolizumab, Abatacept, Sarilumab, Ustekinumab, Ixekizumab, Anakinra)
Exclusion
- Any medical or psychiatric condition which, in the Investigator's opinion, would preclude the participant from completing the study per protocol
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04499001
Start Date
October 1 2019
End Date
July 31 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Cochin
Paris, France